Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.
Esposito E, Marra G, Catalano R, Maioli S, Nozza E, Barbieri AM, Hantel C, Di Dalmazi G, Sigala S, Geginat J, Cassinotti E, Baldari L, Palmieri S, Mangone A, Berruti A, Ferrante E, Mantovani G, Peverelli E. Esposito E, et al. Among authors: peverelli e. Int J Cancer. 2024 Nov 11. doi: 10.1002/ijc.35239. Online ahead of print. Int J Cancer. 2024. PMID: 39528354
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
Treppiedi D, Di Muro G, Marra G, Barbieri AM, Mangili F, Catalano R, Serban A, Ferrante E, Locatelli M, Lania AG, Arosio M, Spada A, Peverelli E, Mantovani G. Treppiedi D, et al. Among authors: peverelli e. Endocr Relat Cancer. 2021 Jun 28;28(8):573-582. doi: 10.1530/ERC-21-0093. Endocr Relat Cancer. 2021. PMID: 34086599
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
Mangili F, Esposito E, Treppiedi D, Catalano R, Marra G, Di Muro G, Barbieri AM, Locatelli M, Lania AG, Mangone A, Spada A, Arosio M, Peverelli E, Mantovani G. Mangili F, et al. Among authors: peverelli e. Front Endocrinol (Lausanne). 2022 Jun 3;13:867822. doi: 10.3389/fendo.2022.867822. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35721701 Free PMC article.
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation.
Treppiedi D, Marra G, Di Muro G, Catalano R, Mangili F, Esposito E, Calebiro D, Arosio M, Peverelli E, Mantovani G. Treppiedi D, et al. Among authors: peverelli e. Front Endocrinol (Lausanne). 2022 Aug 5;13:892668. doi: 10.3389/fendo.2022.892668. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35992099 Free PMC article.
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.
Di Muro G, Mangili F, Esposito E, Barbieri AM, Catalano R, Treppiedi D, Marra G, Nozza E, Lania AGA, Ferrante E, Locatelli M, Arosio M, Peverelli E, Mantovani G. Di Muro G, et al. Among authors: peverelli e. Cancers (Basel). 2023 Jun 16;15(12):3218. doi: 10.3390/cancers15123218. Cancers (Basel). 2023. PMID: 37370829 Free PMC article.
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study.
Catalano R, Altieri B, Angelousi A, Arosio M, Bravi F, Canu L, Croci GA, Detomas M, Esposito E, Ferrante E, Ferrero S, Fuss CT, Kaltsas G, Kimpel O, Landwehr LS, Luconi M, Morelli V, Nesi G, Nozza E, Sbiera S, Serban AL, Ronchi CL, Mantovani G, Peverelli E. Catalano R, et al. Among authors: peverelli e. Int J Mol Sci. 2023 Nov 21;24(23):16573. doi: 10.3390/ijms242316573. Int J Mol Sci. 2023. PMID: 38068896 Free PMC article.
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.
Di Muro G, Catalano R, Treppiedi D, Barbieri AM, Mangili F, Marra G, Di Bari S, Esposito E, Nozza E, Lania AG, Ferrante E, Locatelli M, Modena D, Steinkuhler C, Peverelli E, Mantovani G. Di Muro G, et al. Among authors: peverelli e. Int J Mol Sci. 2024 Mar 23;25(7):3606. doi: 10.3390/ijms25073606. Int J Mol Sci. 2024. PMID: 38612419 Free PMC article.
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.
Catalano R, Giardino E, Treppiedi D, Mangili F, Morelli V, Elli FM, Serban AL, Luconi M, Mannelli M, Spada A, Arosio M, Mantovani G, Peverelli E. Catalano R, et al. Among authors: peverelli e. Cancer Lett. 2021 Jan 28;497:77-88. doi: 10.1016/j.canlet.2020.10.022. Epub 2020 Oct 16. Cancer Lett. 2021. PMID: 33075426
72 results